Skip to main content
Earnings Labs
Inhibikase Therapeutics, Inc. logo

Inhibikase Therapeutics, Inc. (IKT) Earnings

NASDAQ·Healthcare·Biotechnology

$1.55

+1.97%

Mkt Cap $238.61M

EPS — Estimate vs Actual

Mkt Cap

$238.61M

P/E

—

Fwd P/E

—

P/S

—

Rev TTM

—

EPS TTM

-$0.54